In addition, silencing MeCP2 remarkably suppressed breast cancer cell migration by inhibiting β-catenin expression and induced cell apoptosis by downregulating the antiapoptotic gene Bcl-2 and upregulating proapoptotic genes, including Bax, P53, and P21. This evidence concerns the gene BCL2 and breast cancer.